Analyst Ratings February 10, 2026

Rosenblatt Lifts Arista Networks Price Target to $165, Keeps Neutral Call Ahead of Q4 Results

Analyst upgrade reflects fresh hyperscaler wins and steady revenue momentum amid high valuation

By Derek Hwang ANET
Rosenblatt Lifts Arista Networks Price Target to $165, Keeps Neutral Call Ahead of Q4 Results
ANET

Rosenblatt raised its price objective on Arista Networks (NYSE:ANET) to $165 from $140 while retaining a Neutral rating ahead of the company's fourth-quarter earnings. The firm pointed to recent industry checks that uncovered several large contract wins with hyperscalers and cloud AI players, and highlighted Arista’s continued revenue strength and market-share performance at key customers.

Key Points

  • Rosenblatt raised its Arista Networks price target to $165 from $140 while keeping a Neutral rating.
  • Industry checks revealed major wins for Arista, including a $1 billion Ethernet spine contract with Google and a large deal with Anthropic AI, supporting 27.8% revenue growth over the last twelve months.
  • Analysts’ price targets range from $140 to $200; InvestingPro cites a PEG of 2.03 and expects EPS of $2.92 for fiscal 2025.

Rosenblatt this week increased its price target for Arista Networks (NYSE:ANET) to $165.00 from $140.00, while keeping a Neutral rating on the networking-equipment supplier ahead of the company's fourth-quarter earnings announcement. The firm’s reassessment accompanies a string of industry checks that Rosenblatt says show meaningful new business for Arista across hyperscalers and AI-focused customers.

Contract wins cited by Rosenblatt include a $1 billion Ethernet spine engagement with Google that incorporates EoS software, a sizable network agreement with Anthropic AI, and additional opportunities involving Meta, Microsoft and Google in collaboration with Ciena. Rosenblatt connects these wins to Arista’s recent top-line strength; the company has reported 27.8% revenue growth over the past twelve months.

From a market-value perspective, Arista carries a current market capitalization of $178.5 billion and trades at a price-to-earnings ratio of 54. Data from InvestingPro referenced by Rosenblatt indicate that Arista is trading above its internally calculated Fair Value estimate. InvestingPro also classifies Arista as a leading firm in the Communications Equipment industry and assigns it a financial health score of 3.5, labeled as "GREAT."

Rosenblatt expects Arista to record robust fourth-quarter results when the company reports on Thursday, February 12. The firm anticipates that Arista could exceed consensus estimates for the quarter, which stand at $2.38 billion in revenue and $0.76 in earnings per share, and it flagged the potential for expanding deferred revenues as part of the company’s results profile.

Analysts’ price targets collected by InvestingPro range from $140 to $200 for Arista, and consensus projections show an expected EPS of $2.92 for fiscal 2025. Rosenblatt’s latest $165 target is explicitly calculated using a multiple of 40 times consensus 2027 EPS, a valuation approach the firm says underpins its incremental optimism.

Rosenblatt acknowledged persistent market concerns about the potential for AI-accelerated Ethernet networking to favor white-box vendors and new entrants, but said those worries are now better understood. The firm described itself as becoming "incrementally more positive" on Arista as a result of the company’s demonstrated traction in large-scale deals.

Valuation and near-term growth signals remain important contextual factors. InvestingPro flags that Arista is trading at a relatively high earnings multiple when compared with near-term growth expectations, noting a PEG ratio of 2.03. InvestingPro materials referenced additional tips and research coverage for investors evaluating Arista, including a range of analyst price targets and models used to assess Fair Value.

Other recent analyst actions and corporate developments underline divergent views among brokerages even as the company gains commercial traction. Piper Sandler upgraded Arista from Neutral to Overweight and raised its price target to $159, characterizing 2026 as a pivotal year for the company given exposure to hyperscalers, AI-Titans and rising enterprise investments. William Blair and Evercore ISI both reiterated Outperform/Outperform-equivalent ratings, with Evercore ISI setting a $175 price target and noting that Arista preserved a 20% sales growth projection for 2026 despite a negative market reaction to the company’s September quarter results. UBS also maintained a Buy rating with a $155 target.

On the product front, Arista has introduced VESPA, a technology aimed at large-scale campus mobility networks, expanded its Autonomous Virtual Assist capabilities and added ruggedized switches to its portfolio. Rosenblatt and other firms referenced these developments as evidence of Arista’s ongoing strategic initiatives and market presence.

Investors and market participants will be watching the company’s fourth-quarter release for confirmation of the contract momentum Rosenblatt describes and for signs that deferred revenue and order flow support the firm’s forecasted trajectory.

Risks

  • Market concerns that AI-driven Ethernet networking could favor white-box vendors and new entrants, which could affect Arista’s competitive position - impacts Communications Equipment and Cloud Infrastructure sectors.
  • High valuation metrics relative to near-term growth, including a P/E of 54 and a PEG of 2.03, which may leave the stock vulnerable to earnings or guidance misses - impacts Equity Markets and Technology sector sentiment.
  • Potential for investor reaction to quarterly results if revenue, EPS or deferred revenue trends fall short of elevated expectations, affecting network equipment suppliers and hyperscaler suppliers.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026